Use of Livers from Hepatitis B Core Antibody Positive Donors in Living Donor Liver Transplantation

Yaprak O., Dayangac M., BALCI D., Demirbas T., Yuzer Y., Tokat Y.

HEPATO-GASTROENTEROLOGY, vol.57, no.102-03, pp.1268-1271, 2010 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 57 Issue: 102-03
  • Publication Date: 2010
  • Journal Name: HEPATO-GASTROENTEROLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1268-1271
  • Keywords: De novo hepatitis B, Liver transplantation, Anti-HBc positive donor, VIRUS-INFECTION, IMMUNE GLOBULIN, LAMIVUDINE, HBC, PROPHYLAXIS, PREVENTION, ALLOGRAFTS, TRANSMISSION, ANTIGEN, RISK
  • Marmara University Affiliated: No

Abstract

Background/Aims: HBsAg negative recipients of liver from anti-HBc positive donors are at a significant risk for developing de novo HBV infection after liver transplantation. The aim of this study was to assess the efficacy of lamivudine as mono therapy in preventing HBV transmission by graft with anti-HBc positive donors.